Furthermore, it induces an immunosuppressive tumor microenvironment, resulting in a strong suppression of anti-tumor immune responses, consistent with the critical role of the JAK/STAT signaling pathway in chronic inflammation and inflammation-mediated progression of cancer,[24–26] which is often associated with poor patient prognosis. The gene discussed is SOAT1; the disease is cancer.